Substance use is a complex issue impacting millions of individuals and communities across the nation and worldwide. Historically, abstinence-based recovery models have been the predominant approach used by many, and they have been effective for some. In recent years, more attention has been given to harm reduction–a compassionate, evidence-based alternative that meets individuals where they are in their recovery journey. Harm reduction recognizes that substance use is a reality in our society and focuses on minimizing the risks of substance use rather than enforcing complete abstinence.
What is Harm Reduction?
Harm reduction is a compassionate approach that focuses on the health, dignity, and autonomy of people by collaborating and providing them with strategies to minimize the risks associated with substance use. Instead of enforcing an all-or-nothing model, providers work with people who use substances to implement attainable strategies to minimize risk. The harm reduction model acknowledges that people may not be ready or able to stop using substances immediately and completely, and offers support to help them stay safe and improve their well-being.
Some key principles of harm reduction include:
- Meeting people where they are – without judgment
- Providing safer use strategies – such as supervised safe consumption sites (though these are not widespread throughout the country), fentanyl test strips, Naloxone and needle exchange programs
- Encouraging incremental change – recognizing that small steps can lead to big successes
- Prioritizing health and safety – through overdose prevention education and access to care
- Reducing stigma – so people feel comfortable to seek help
Why Harm Reduction Matters
Harm reduction is scientifically proven to save lives. Research shows that harm reduction programs help prevent overdose deaths, reduce infectious disease transmission, and increase engagement and trust with healthcare providers (Hawk et al., 2017).
For example:
-Needle exchange programs significantly reduce the spread of HIV and hepatitis C by providing sterile injection equipment.
-Medication for Addiction Treatment (MAT), such as methadone or buprenorphine, help people reduce opioid dependence without forcing complete abstinence.
-Harm reduction supports not only physical health but also social and emotional well-being. By reducing stigma and punitive approaches, people who use substances are more likely to seek support, engage with healthcare providers, and make positive changes in their lives.
References
Hawk, M., Coulter, R. W., Egan, J. E., Fisk, S., Friedman, M. R., Tula, M., & Kinsky, S. (2017). Harm reduction principles for healthcare settings. Harm Reduction Journal, 14(1), 70.
Strang, J., Groshkova, T., & Metrebian, N. (2018). New heroin-assisted treatment: Recent evidence and current practices of supervised injectable heroin treatment in Europe and beyond. Neuropharmacology, 142, 28-36.
About Annie Saroyan – Registered Associate Clinical Social Worker Therapist I
Annie Saroyan is a substance use therapist who has been working at Didi Hirsch Outpatient Substance Use Treatment program since November 2024. She earned her master’s degree in social work from the University of Southern California in August 2024. She takes a client-centered approach, recognizing the impact of different systems and policies on individuals in recovery. Annie uses harm reduction, motivational interviewing, and trauma-informed care to support her clients in building coping skills and making meaningful changes toward their goals.
